Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VTGN stock hub

Vistagen Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VTGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VTGN

In the news

Latest news · VTGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-101.6

P25 -106.6P50 -46.9P75 -3.1

ROIC-64.6

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VTGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001411685
Company name	Vistagen Therapeutics, Inc.
Country	United States
Country code	US
Cusip	92840H202
Employees	59
Employees Change	14%
Employees Change Percent	31.11
Enterprise value	$-36.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US92840H4002
Last refreshed	2026-05-10
Market cap	$24.2M
Market cap category	Nano-Cap
Price	$0.61
Price currency	USD
Rev Per Employee	13,372.88x
Sector	Healthcare
Sic	2834
Symbol	VTGN
Website	https://www.vistagen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-277.18%
FCF yield	-250.27%
P/B ratio	0.48x
P/S ratio	30.66x
PS Forward	20.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$789,000
Gross Profit Growth	13.04%
Gross Profit Growth Q	29.49%
Gross Profit Growth5 Y	4.03%
Net Income	$-67M
Net Income Growth Years	0%
Pretax Margin	-8,497.59%
Profit Per Employee	$-1.1M
ROA	-55.53
Roa5y	-38.37
ROCE	-135.7
ROE	-101.6
Roe5y	-70.37
ROIC	-64.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-44.24%
Cagr1y	-71.76%
Cagr3y	-44.99%
Cagr5y	-62.01%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	13.04x
Revenue Growth Q	29.49x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth5 Y	4.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$65.1M
Cash	$61.8M
Current Assets	$63.2M
Current Liabilities	$13.5M
Debt	$1.4M
Debt Equity	$0.03
Equity	$50.9M
Liabilities	$14.1M
Long Term Assets	$1.8M
Long Term Liabilities	$607,000
Net Cash	$60.3M
Net Cash By Market Cap	$249
Net Cash Growth	-30.52%
Net Debt Equity	$-1.19
Tangible Book Value	$50.9M
Tangible Book Value Per Share	$1.29
WACC	5.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.67
Net Working Capital	$-11.1M
Quick ratio	4.57
Working Capital	$49.7M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.56%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.71%
1Y total return	-71.74%
200-day SMA	2.19
3Y total return	-83.36%
50-day SMA	0.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.21%
All Time High	1,890
All Time High Change	-99.97%
All Time High Date	2012-01-04
All Time Low	0.43
All Time Low Change	41.98%
All Time Low Date	2026-02-13
ATR	0.04
Beta	0.3
Beta1y	0.73
Beta2y	0.71
Ch YTD	-7.77
High	0.64
High52	5.14
High52 Date	2025-11-24
High52ch	-88.12%
Low	0.6
Low52	0.43
Low52 Date	2026-02-13
Low52ch	41.98%
Ma50ch	2.04%
Premarket Change Percent	1.74
Premarket Price	$0.6
Premarket Volume	44,381
Price vs 200-day SMA	-72.09%
RSI	52.19
RSI Monthly	34.89
RSI Weekly	31.21
Sharpe ratio	-0.18x
Sortino ratio	-0.16
Total Return	-15.56%
Tr YTD	-7.77
Tr1m	13.94%
Tr1w	-2.44%
Tr3m	8.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Hold
Earnings EPS Estimate	$-0.3
Earnings Revenue Estimate	276,000x
Operating Income	$-69.9M
Operating margin	-8,859.8
Price target	$0.9
Price Target Change	$47.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,777,542%
Float Percent	85.25%
Net Borrowing	378,000
Shares Insiders	0.27%
Shares Institutions	25.88%
Shares Out	39,620,317
Shares Qo Q	18.14%
Shares Yo Y	15.56%
Short Float	5.07%
Short Ratio	3.34
Short Shares	4.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-64.6M
Average Volume	955,253.9x
Bv Per Share	1.29
CAPEX	$-239,000
Ch10y	-99.71
Ch1m	13.94
Ch1w	-2.44
Ch1y	-71.74
Ch3m	8.4
Ch3y	-83.36
Ch5y	-99.21
Ch6m	-84.7
Change	4.04%
Change From Open	2.19
Close	0.59
Days Gap	1.81
Depreciation Amortization	187,000
Dollar Volume	721,349.1
Earnings Date	2026-06-16
Earnings Time	amc
EBIT	$-69.9M
EBITDA	$-69.7M
EPS	$-1.89
F Score	2
FCF	$-60.5M
FCF EV Yield	167.44x
FCF Per Share	$-1.53
Financing CF	33,205,000
Fiscal Year End	March
Founded	1,998
Investing CF	-251,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2023-06-07
Last Split Type	Reverse
Last10k Filing Date	2025-06-17
Ma150	1.85
Ma150ch	-66.95%
Ma20	0.6
Ma20ch	1.48%
Net CF	-27,344,000
Next Earnings Date	2026-06-16
Open	0.6
Optionable	Yes
Position In Range	32.49
Post Close	0.61
Postmarket Change Percent	1.97
Postmarket Price	$0.62
Ppne	1,419,000
Pre Close	0.59
Price Date	2026-05-08
Ptbv Ratio	0.48
Relative Volume	1.24x
Revenue	789,000x
SBC By Revenue	515.97x
Share Based Comp	4,071,000
Tr6m	-84.7%
Us State	California
Volume	1,181,571
Z Score	-8.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VTGN pay a dividend?

Capital-return profile for this ticker.

Performance

VTGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VTGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.9%

Float: +85.3% of shares outstanding

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VTGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.2

Neutral momentum band

Price vs 200-day MA

-72.1%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

-0.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VTGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VTGN stock rating?

Vistagen Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VTGN analysis?

The full report lives at /stocks/VTGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VTGN?

The latest report frames VTGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VTGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.